Thomas J Scriba

Title: Thomas J Scriba: Innovator in HIV Research

Introduction

Thomas J Scriba is a notable inventor based in Oxford, GB. He has made significant contributions to the field of HIV research, particularly in the development of immunogenic polypeptides. With a total of 2 patents, his work has implications for immunization and the production of HIV-related proteins.

Latest Patents

Scriba's latest patents include innovations related to HIV-1 South African subtype C env proteins. The first patent describes polynucleotides encoding immunogenic HIV polypeptides, detailing their uses in immunization, generation of packaging cell lines, and production of HIV polypeptides. The second patent focuses on expression cassettes encoding modified immunogenic HIV-1 South African subtype C Env polypeptides, which include deletions in the V1, V2, and stem regions. These innovations are crucial for advancing HIV research and treatment.

Career Highlights

Throughout his career, Thomas J Scriba has worked with prominent organizations such as Novartis Vaccines & Diagnostics and the University of Stellenbosch. His experience in these institutions has allowed him to collaborate on groundbreaking research in the field of immunology and virology.

Collaborations

Scriba has collaborated with notable colleagues, including Jan Zur Megede and Susan Barnett. These partnerships have contributed to the advancement of his research and the development of innovative solutions in HIV treatment.

Conclusion

Thomas J Scriba's contributions to HIV research through his patents and collaborations highlight his role as an important inventor in the field. His work continues to influence the development of immunogenic therapies and the understanding of HIV.